ABL has developed several antigen capture assays to support researchers in their SIV and HIV-1 related project work. Each ELISA kit is based on a simple, easy to use design that provides the user with reliable results in as little as 2 ½ hours. Our kits also offer greater sensitivity with lower levels of detection of 3.1 pg/ml for our p24 kit and 62.5 pg/ml for our SIV-1 p27 and HIV-1 gp120 kits.
Click on the Catalog Products link in the page header to order one of the products described below.
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
|
References for our kits include:
HIV-1 p24 Antigen Capture Assay (CAT#: 5421 and 5447)
Kuroishi, A., Saito, A., Shigai, Y., Shioda, T., Nomaguchi, M., Adachi, A., Akari, H., Nakayama, E. Modification of a Loop Sequence between Alpha Helices 6 and 7 of Virus Capsid (CA) Protein in a Human Immunodeficiency Virus Type I (HIV-1) Derivative that has Simian Immunodeficiency Virus (SIVmac239) vif and CA Alpha-Helices 4 and 5 Loop Improves Replication in Cynomolgus Monkey Cells. Retrovirology, 6:70. 2009.
Humeau, L., Binder, G., Lu, X., Slepushkin, V., Merling, R., Echeagaray, P., Pereira, M., Slepushkina, T., Barnett, S., Dropulic, L., Carroll, R., Levine, B., June, C., Dropulic, B. Efficient Lentiviral Vector-Mediated Control of HIV-1 Replication in CD4 Lymphocytes from Diverse HIV+ Infected Patients Grouped According to CD4 Count and Viral Load. Molecular Therapy 9(6): 902-913. 2004.
HIV-1 gp120 Antigen Capture Assay (CAT#: 5429)
Megati, S., Garcia-Hand, D., Cappello, S., Roopchand, V., Masood, A., Xu, R., Luckay, A., Chong, S., Rosati, M., Sackitey, S., Weiner, D., Felber, B., Pavlakis, G., Israel, Z., Smith, L., Eldridge, J., Sidhu, M., Egan, M. Modifying the HIV-1 env gp160 Gene to Improve pDNA Vaccine-Elicited Cell-Mediated Immune Responses. Vaccine 26:5083-5094. 2008.
Santosuosso, M., Righi, E., Lindstrom, V., Leblanc, P., Poznansky, M. HIV-1 Envelope Protein gp120 is Present at High Concentrations in Secondary Lymphoid Organs of Individuals with Chronic HIV-1 Infection. Journal of Infectious Diseases 200:1050-1053. 2009.
SIV-1 p27 Antigen Capture Assay (CAT#: 5436 and 5450)
Johnson, P., Schnepp, B., Zhang, J., Connell, M., Greene, S., Yuste, E., Desrosiers, R., Clark, K., Vector-Mediated Gene Transfer Engenders Long Lived Neutralization Activity and Protection Againist SIV Infection in Monkeys. Nature Medicine. 15(8):901-907; 2009.
Kuroishi, A., Saito, A., Shigai, Y., Shioda, T., Nomaguchi, M., Adachi, A., Akari, H., Nakayama, E. Modification of a Loop Sequence between Alpha Helices 6 and 7 of Virus Capsid (CA) Protein in a Human Immunodeficiency Virus Type I (HIV-1) Derivative that has Simian Immunodeficiency Virus (SIVmac239) vif and CA Alpha-Helices 4 and 5 Loop Improves Replication in Cynomolgus Monkey Cells. Retrovirology, 6:70. 2009.
Kish-Catalone, T., Pal, R., Parrish, J., Rose, N., Hocker, L., Hudacik, L., Reitz, M., Gallo, R., Devico, A. Evaluation of -2 Rantes Vaginal Microbicide Formulations in a Nonhuman Primate Simian/Human Immunodeficiency Virus (SHIV) Challenge Model. AIDS Research and Human Retroviruses, 23(1);33-42. 2007.
Hidajat, R., Xiao, P., Qifeng, Z., Venzon, D., Summers, L., Vaniambadi, S., Montefiori, D., Robert-Guroff, M. Correlation of Vaccine Elicited Systemic and Mucosal Nonneutralizing antibody activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques. Journal of Virology. 83(2):791-801; 2009
Jia, B., Ng, S., DeGottardi, M., Piatak, M., Yuste, E., Carville, A., Mansfield, K., Li, W., Richardson, B., Lifson, J., Evans, D. Immunization with Single Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIVmac239. PLos Pathogens 5(1):e1000272. 2009.
We would like to learn more about the research you are performing with our kits. Please email us any references where our kits our mentioned.














